ETRA logo

Electra Therapeutics Inc.

ETRA
Healthcare|Medical - Pharmaceuticals|US
$7.80
+0.45 (+6.12%)
Financing Filings (last 12 months)
4
Shelf registrations / offering prospectuses — latest Sep 18, 2026 (424B4). Possible dilution.

Upcoming Data Readouts (2)

Mar 2028
Est. completion
P2P3Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
NCT05416307n=156
Jun 2028
Est. completion
P1T Cell Malignancies
A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs)
NCT07465835n=84

Recent Press Releases

Electra Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference in London
Nov 4, 2026 · GlobeNewsWire
Kinzey Capital Management: Electra Sets Nasdaq IPO Terms
Sep 19, 2026 · GlobeNewsWire
Electra Therapeutics Announces Pricing of Upsized $350.0 Million Initial Public Offering
Sep 17, 2026 · GlobeNewsWire

SEC Filings (16)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Oct 29, 2026SC 13GPassive 5%+ stakeDocumentIndex
Sep 28, 2026SC 13GPassive 5%+ stakeDocumentIndex
Sep 28, 2026SC 13GPassive 5%+ stakeDocumentIndex
Sep 25, 2026SC 13DActivist / 5%+ stakeDocumentIndex
Sep 21, 2026S-8Employee stock planDocumentIndex
Sep 21, 20268-KMaterial eventDocumentIndex
Sep 18, 2026424B4Offering prospectusDocumentIndex
Sep 18, 2026CERTDocumentIndex
Sep 18, 20268-A12BDocumentIndex
Sep 17, 2026EFFECTDocumentIndex
Sep 17, 2026S-1MEFIPO / offering registrationDocumentIndex
Sep 14, 2026S-1/AIPO / offering registrationDocumentIndex
Aug 28, 2026S-1IPO / offering registrationDocumentIndex
Aug 10, 2026DRS/ADocumentIndex
Jun 26, 2026DRSDocumentIndex
Oct 30, 2025DDocumentIndex